Literature DB >> 20017162

Radiofrequency and microwave ablation of lung tumors.

Ghulam Abbas1, Arjun Pennathur, Rodney J Landreneau, James D Luketich.   

Abstract

Lung cancer is the most common cause of cancer-related mortality in the United States. Surgical resection remains the standard treatment for early stage, non-small cell lung cancer, and limited pulmonary metastases. However, many patients with resectable disease have significant co-morbidities which preclude surgical resection. Radiofrequency and microwave ablation are emerging modalities of treatment for these high-risk patients. Here, we review the principles, common devices in use, and treatment results of ablative therapy for lung tumors. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 20017162     DOI: 10.1002/jso.21334

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  17 in total

1.  Dual-slot antennas for microwave tissue heating: parametric design analysis and experimental validation.

Authors:  Christopher L Brace
Journal:  Med Phys       Date:  2011-07       Impact factor: 4.071

Review 2.  Thermal ablation of stage I non-small cell lung carcinoma.

Authors:  Carol A Ridge; Stephen B Solomon; Raymond H Thornton
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

Review 3.  Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time?

Authors:  Millie Das; Mohamed H K Abdelmaksoud; Billy W Loo; Nishita Kothary
Journal:  Curr Treat Options Oncol       Date:  2010-06

Review 4.  Catheter-based alternative treatment for early-stage lung cancer with a high-risk for morbidity.

Authors:  Ze-Rui Zhao; Rainbow W H Lau; Calvin S H Ng
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

5.  Radiofrequency ablation technique eradicating palpebral margin neoplasm.

Authors:  Tian-Yu Jiang; Xing-Lin Wang; Wei Suo; Qing-Hua He; Hong-Yu Xiao
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

Review 6.  Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.

Authors:  Guy C Jones; Jason D Kehrer; Jenna Kahn; Bobby N Koneru; Ram Narayan; Tarita O Thomas; Kevin Camphausen; Minesh P Mehta; Aradhana Kaushal
Journal:  Clin Lung Cancer       Date:  2015-04-23       Impact factor: 4.785

7.  Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases.

Authors:  Xia Yang; Xin Ye; Aimin Zheng; Guanghui Huang; Xiang Ni; Jiao Wang; Xiaoying Han; Wenhong Li; Zhigang Wei
Journal:  J Surg Oncol       Date:  2014-06-25       Impact factor: 3.454

8.  Radiofrequency ablation of thoracic tumours: lessons learned with ablation of 100 lesions.

Authors:  Irene Garetto; Marco Busso; Diego Sardo; Claudia Filippini; Federica Solitro; Maria Luisa Grognardi; Andrea Veltri
Journal:  Radiol Med       Date:  2013-11-15       Impact factor: 3.469

9.  Radiofrequency-induced small bowel thermofusion: an ex vivo study of intestinal seal adequacy using mechanical and imaging modalities.

Authors:  Shobhit Arya; Nancy Hadjievangelou; Su Lei; Hiromi Kudo; Robert D Goldin; Ara W Darzi; Daniel S Elson; George B Hanna
Journal:  Surg Endosc       Date:  2013-04-10       Impact factor: 4.584

10.  Radiofrequency ablation of lung tumours.

Authors:  Irene Bargellini; Elena Bozzi; Roberto Cioni; Barbara Parentini; Carlo Bartolozzi
Journal:  Insights Imaging       Date:  2011-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.